Dr. Steve Nissen talks about three trials presented at the 2020 American Heart Association Scientific Sessions: the STRENGTH trial, which looked at omega 3 fatty acid’s impact on cardiovascular events, the STOP AF trial that studied medication vs. ablation in treating patients with new onset atrial fibrillation; and the RHAPSODY trial, which looked at the drug rilonacept in the treatment of recurrent pericarditis. He also provides his take on a couple additional trials looking at statin intolerance and a polypill for heart disease.
